Prophylactic use of standardized extract of propolis of Apis mellifera (EPP-AF®) reduces lung inflammation and improves survival in experimental lethal sepsis.

[1]  E. Fernandes,et al.  The Immunomodulatory Activity of Punica granatum L. Peel Extract Increases the Lifespan of Mice with Lethal Sepsis , 2023, Journal of immunology research.

[2]  T. Cerqueira-Silva,et al.  Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial , 2021, Biomedicine & Pharmacotherapy.

[3]  M. Shimizu,et al.  Green propolis extract attenuates acute kidney injury and lung injury in a rat model of sepsis , 2021, Scientific Reports.

[4]  D. De Jong,et al.  Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease , 2020, Biomedicine & Pharmacotherapy.

[5]  E. Rojczyk,et al.  Historical and modern research on propolis and its application in wound healing and other fields of medicine and contributions by Polish studies. , 2020, Journal of ethnopharmacology.

[6]  H. Maruta,et al.  PAK1-blockers: Potential Therapeutics against COVID-19 , 2020, Medicine in Drug Discovery.

[7]  E. M. de Sousa,et al.  Pic-Producing Escherichia coli Induces High Production of Proinflammatory Mediators by the Host Leading to Death by Sepsis , 2020, International journal of molecular sciences.

[8]  C. Hartog,et al.  Life after sepsis: an international survey of survivors to understand the post-sepsis syndrome. , 2019, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[9]  J. R. Nascimento,et al.  The anti-inflammatory activity of Anacardium occidentale L. increases the lifespan of diabetic mice with lethal sepsis. , 2019, Journal of ethnopharmacology.

[10]  J. R. Nascimento,et al.  Prophylactic Treatment With Simvastatin Modulates the Immune Response and Increases Animal Survival Following Lethal Sepsis Infection , 2018, Front. Immunol..

[11]  C. Coopersmith,et al.  Increased mortality in CD43-deficient mice during sepsis , 2018, PloS one.

[12]  Mitchell M. Levy,et al.  The Surviving Sepsis Campaign Bundle: 2018 update , 2018, Intensive Care Medicine.

[13]  A. Mahmoud,et al.  Caffeic acid phenethyl ester protects the brain against hexavalent chromium toxicity by enhancing endogenous antioxidants and modulating the JAK/STAT signaling pathway. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  J. R. Nascimento,et al.  Chenopodium ambrosioides L. Improves Phagocytic Activity and Decreases Bacterial Growth and the Systemic Inflammatory Response in Sepsis Induced by Cecal Ligation and Puncture , 2017, Front. Microbiol..

[15]  Tao Wu,et al.  Caffeic acid phenethyl ester attenuates lipopolysaccharide‐stimulated proinflammatory responses in human gingival fibroblasts via NF‐&kgr;B and PI3K/Akt signaling pathway , 2017, European journal of pharmacology.

[16]  S. Gemma,et al.  The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation , 2016, Mediators of inflammation.

[17]  M. Balaan,et al.  Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.

[18]  T. Rea,et al.  Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[19]  Adil Rafiq Rather,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .

[20]  V. Borges,et al.  Tityus serrulatus scorpion venom improves survival and lung inflammation in lethal sepsis induced by CLP in mice. , 2014, Toxicon : official journal of the International Society on Toxinology.

[21]  M. Levy,et al.  Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program* , 2014, Critical care medicine.

[22]  Lucilene A Silva,et al.  Effects of Stingless Bee Propolis on Experimental Asthma , 2014, Evidence-based complementary and alternative medicine : eCAM.

[23]  O. Barth,et al.  Botanical origin and Artepillin-C content of Brazilian propolis samples , 2013 .

[24]  G. Goldman,et al.  The Inhibition of Inflammasome by Brazilian Propolis (EPP-AF) , 2013, Evidence-based complementary and alternative medicine : eCAM.

[25]  P. Salameh,et al.  Statins decrease mortality in Lebanese patients with sepsis: A multicenter study , 2013, Pharmacy practice.

[26]  B. Rocha,et al.  Brazilian Green Propolis: Anti-Inflammatory Property by an Immunomodulatory Activity , 2012, Evidence-based complementary and alternative medicine : eCAM.

[27]  J. M. Marchetti,et al.  Propolis Standardized Extract (EPP-AF®), an Innovative Chemically and Biologically Reproducible Pharmaceutical Compound for Treating Wounds , 2012, International journal of biological sciences.

[28]  T. Lagu,et al.  Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007 , 2012, Critical care medicine.

[29]  F. R. Nascimento,et al.  Mechanisms of action underlying the anti-inflammatory and immunomodulatory effects of propolis: a brief review , 2012 .

[30]  A. A. Korish,et al.  Propolis derivatives inhibit the systemic inflammatory response and protect hepatic and neuronal cells in acute septic shock. , 2011, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[31]  Masayuki Ii,et al.  Combination of Imipenem and TAK-242, a Toll-Like Receptor 4 Signal Transduction Inhibitor, Improves Survival in a Murine Model of Polymicrobial Sepsis , 2011, Shock.

[32]  Anand Kumar,et al.  Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. , 2009, Chest.

[33]  G. Martin,et al.  Recent trends in acute lung injury mortality: 1996–2005* , 2009, Critical care medicine.

[34]  A. Vollmar,et al.  Anti-inflammatory effects of a bioavailable compound, Artepillin C, in Brazilian propolis. , 2008, European journal of pharmacology.

[35]  F. R. Nascimento,et al.  Anti-thrombotic effect of chronic oral treatment with Orbignya phalerata Mart. , 2007, Journal of ethnopharmacology.

[36]  E. Vieira,et al.  Atividade antimicrobiana de própolis de Apis mellifera obtidas em três regiões do Brasil , 2006 .

[37]  Y. Yamori,et al.  Downregulation of Rac1 activation by caffeic acid in aortic smooth muscle cells. , 2005, Life sciences.

[38]  M. Rojas,et al.  Endotoxin-induced lung injury in mice: structural, functional, and biochemical responses. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[39]  D. Remick,et al.  Humane Endpoints in Shock Research , 2004, Shock.

[40]  U. Lendeckel,et al.  Propolis and Some of its Constituents Down-Regulate DNA Synthesis and Inflammatory Cytokine Production but Induce TGF-β1 Production of Human Immune Cells , 2003, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[41]  Z. Fortes,et al.  Inhibition of Leukocyte Rolling by Nitric Oxide during Sepsis Leads to Reduced Migration of Active Microbicidal Neutrophils , 2002, Infection and Immunity.

[42]  F. Mach,et al.  Statins as a newly recognized type of immunomodulator , 2000, Nature Medicine.

[43]  M. Gupta,et al.  Antitumor activity of methanolic extract of Cassia fistula L. seed against Ehrlich ascites carcinoma. , 2000, Journal of ethnopharmacology.

[44]  F. Stentz,et al.  Clinical Investigations in Critical CarePersistent Elevation of Inflammatory Cytokines Predicts a Poor Outcome in ARDS: Plasma IL-1β and IL-6 Levels Are Consistent and Efficient Predictors of Outcome Over Time , 1995 .

[45]  I. Chaudry,et al.  Sepsis and septic shock--a review of laboratory models and a proposal. , 1980, The Journal of surgical research.

[46]  M. Russo,et al.  Bmc Complementary and Alternative Medicine Syzygium Jambolanum Treatment Improves Survival in Lethal Sepsis Induced in Mice , 2008 .

[47]  M. Sitkovsky,et al.  Model organisms: Animal Models of sepsis: setting the stage , 2005, Nature Reviews Drug Discovery.

[48]  J. M. Sforcin,et al.  Seasonal effect of brazilian propolis on Candida albicans and Candida tropicalis , 2001 .

[49]  S. T. A. Cassini,et al.  Efeito de extratos de própolis verde sobre bactérias patogênicas isoladas do leite de vacas com mastite , 2001 .

[50]  C. A. Lopes,et al.  IN VITRO ACTIVITY OF PROPOLIS AGAINST BACTERIAL AND YEAST PATHOGENS ISOLATED FROM HUMAN INFECTIONS , 1995 .